Operating Income for Abbott Laboratories (ABT)
According to Abbott Laboratories's latest reported financial statements, the company's current operating income (TTM) is $8.20B USD. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingOperating IncomeSwitch metric
TTM (last 4 quarters)
$8.20B
YoY change
+17.9%
5Y CAGR
+8.8%
Peak year (2021)
$9.20B
Cumulative operating income
$151.54B
Operating Income history chart for Abbott Laboratories (ABT) from 1985 to 2025
Operating Income history table for Abbott Laboratories (ABT) from 1985 to 2025
| Fiscal year | Period ended | Reported | Operating Income | YoY |
|---|---|---|---|---|
| 2025 | $8.05B | +17.9% | ||
| 2024 | $6.83B | +6.1% | ||
| 2023 | $6.43B | -23.0% | ||
| 2022 | $8.36B | -9.1% | ||
| 2021 | $9.20B | +73.9% | ||
| 2020 | $5.29B | +15.2% | ||
| 2019 | $4.59B | +19.4% | ||
| 2018 | $3.84B | +94.9% | ||
| 2017 | $1.97B | -39.3% | ||
| 2016 | $3.25B | +10.2% | ||
| 2015 | $2.95B | +1.1% | ||
| 2014 | $2.92B | +35.9% | ||
| 2013 | $2.15B | +6.9% | ||
| 2012 | $2.01B | -70.7% | ||
| 2011 | $6.84B | -3.0% | ||
| 2010 | $7.05B | +7.3% | ||
| 2009 | $6.57B | +7.9% | ||
| 2008 | $6.09B | +23.1% | ||
| 2007 | $4.95B | +14.1% | ||
| 2006 | $4.34B | -6.7% | ||
| 2005 | $4.65B | +11.3% | ||
| 2004 | $4.18B | +40.5% | ||
| 2003 | $2.97B | -5.6% | ||
| 2002 | $3.15B | +66.4% | ||
| 2001 | $1.89B | -44.3% | ||
| 2000 | $3.40B | +8.0% | ||
| 1999 | $3.15B | +1.0% | ||
| 1998 | $3.12B | +9.4% | ||
| 1997 | $2.85B | +8.9% | ||
| 1996 | $2.62B | +9.8% | ||
| 1995 | $2.38B | +11.1% | ||
| 1994 | $2.14B | +11.4% | ||
| 1993 | $1.92B | +26.1% | ||
| 1992 | $1.53B | -2.0% | ||
| 1991 | $1.56B | +10.7% | ||
| 1990 | $1.41B | +15.1% | ||
| 1989 | $1.22B | +10.8% | ||
| 1988 | $1.10B | +9.6% | ||
| 1987 | $1.01B | +14.5% | ||
| 1986 | $878.60M | +19.2% | ||
| 1985 | $737.10M | — |
Operating Income values are taken from Abbott Laboratories's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Abbott Laboratories (ABT) operating income totalled $8.05B – grew 17.9% year-over-year.
Over 2020–2025 (5 years), Abbott Laboratories operating income expanded at a +8.8% compound annual rate, sustaining 2 straight years of year-over-year growth.
Between 2021 and 2025, Abbott Laboratories operating income declined 12.5%, falling from $9.20B to $8.05B.
$9.20B stands as the all-time-high annual operating income, posted in 2021, against a low of $737.10M during 1985.
Within Healthcare, Abbott Laboratories (ABT) ranks 9th among 8 peers we track. The peer median for operating income is $22.84B.
Abbott Laboratories Operating Income by Year
Abbott Laboratories Operating Income 2025: $8.05B
Abbott Laboratories operating income in 2025 was $8.05B, grew 17.9% from 2024.
Abbott Laboratories Operating Income 2024: $6.83B
Abbott Laboratories operating income in 2024 was $6.83B, grew 6.1% from 2023.
Abbott Laboratories Operating Income 2023: $6.43B
Abbott Laboratories operating income in 2023 was $6.43B, declined 23.0% below 2022.
Abbott Laboratories Operating Income 2022: $8.36B
Abbott Laboratories operating income in 2022 was $8.36B, declined 9.1% below 2021.
Abbott Laboratories Operating Income 2021: $9.20B
Abbott Laboratories operating income in 2021 was $9.20B.
See more financial history for Abbott Laboratories (ABT).
Sector peers — Operating Income
Companies in the same sector as Abbott Laboratories, ranked by their latest operating income.
| Company | Operating Income | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $127.66B | Healthcare |
| Eli Lilly and Company (LLY) | $29.70B | Healthcare |
| Merck & Co., Inc. (MRK) | $26.78B | Healthcare |
| Johnson & Johnson (JNJ) | $25.60B | Healthcare |
| AbbVie Inc. (ABBV) | $20.09B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $18.96B | Healthcare |
| AstraZeneca PLC (AZN) | $13.74B | Healthcare |
| Amgen Inc. (AMGN) | $10.68B | Healthcare |
Frequently asked questions
What is Abbott Laboratories's operating income?
- Latest reported operating income for Abbott Laboratories (ABT) is $8.20B (period ending March 31, 2026).
How has Abbott Laboratories operating income changed year-over-year?
- Abbott Laboratories (ABT) operating income changed +17.9% year-over-year on the latest annual filing.
What is the long-term growth rate of Abbott Laboratories operating income?
- Abbott Laboratories (ABT) operating income compound annual growth rate is +8.8% over the most recent 5 years available.
When did Abbott Laboratories operating income hit its highest annual value?
- Abbott Laboratories operating income reached its highest annual value of $9.20B in 2021.
What was Abbott Laboratories operating income in 2024?
- Abbott Laboratories (ABT) operating income in 2024 was $6.83B.
What was Abbott Laboratories operating income in 2025?
- Abbott Laboratories (ABT) operating income in 2025 was $8.05B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
ABT Overview
Company profile, financial tools, and key metrics
ABT Revenue Counter
Earns $1,431 every second. See per minute, hour, and day.
ABT Earnings Counter
Earns $199.01 per second net profit. See per minute, hour, and day.
ABT Economic Scale
Exceeds Paraguay's GDP. Compare with world economies.
ABT What If Invested
What if you had invested $1,000? See historical returns from any date.
ABT How It Makes Money
Discover visual breakdown of $45.13B in revenue — where it comes from and where it goes.
ABT Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
ABT Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
ABT Daily Price Character
Steady · 48.2% historical win rate (green days). Streaks & record days.
ABT Buybacks
0.41% TTM buyback yield. Shareholder yield & SBC comparison.
ABT Stock Split History
9 splits on record. Dates, ratios, and cumulative multiple.
ABT Dividend Profile
Yield: 2.67%. Safety: 6/8. See full history.
ABT Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
ABT Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.